MedTrace Logo

Gut Hormones and Bone Remodeling in Humans (KS-2)

NCT03573934 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2020-01-18

No results posted yet for this study

Summary

Effects of GLP-2 and GIP on bone remodeling in healthy young men.

Conditions

  • Healthy

Interventions

OTHER

GLP-2

GLP-2

OTHER

GIP

GIP

OTHER

GLP-2+GIP

GLP-2+GIP

OTHER

Placebo

Placebo

Sponsors & Collaborators

  • Hvidovre University Hospital

    collaborator OTHER

  • University of Copenhagen

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-15
Primary Completion
2018-03-15
Completion
2018-03-15

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03573934 on ClinicalTrials.gov